Programmed Cell Death Protein Ligand 2 Is a Potential Biomarker That Predicts the Efficacy of Immunotherapy

Immune checkpoint inhibitor (ICI) responses vary, and biomarkers for predicting responders are urgently needed. Growing evidence points to the association between programmed cell death protein ligand 2 (PDL2) and ICI benefits, while clinical evidences were lacking. Thus, we consolidated five public...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Aoyun, Chu, Han, Jin, Zheng, Jia, Qingzhu, Zhu, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572643/
https://www.ncbi.nlm.nih.gov/pubmed/34754345
http://dx.doi.org/10.1155/2021/9453692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572643/
https://www.ncbi.nlm.nih.gov/pubmed/34754345
http://dx.doi.org/10.1155/2021/9453692

Ejemplares similares